Clinical, epidemiological and virological features of dengue virus infections in vietnamese patients...

14
Clinical, epidemiological and virological features of dengue virus infections in vietnamese patients presenting to primary care facilities with acute undifferentiated fever Khoa T.D. Thai a,b,c,, Hoang Lan Phuong a,g , Tran Thi Thanh Nga e , Phan Trong Giao g , Le Quoc Hung g , Nguyen Van Nam f , Tran Quang Binh g , Cameron Simmons b,h , Jeremy Farrar b,h , Tran Thinh Hien b , H. Rogier van Doorn b,h , Menno D. de Jong b,d,h , and Peter J. de Vries a,c a Division of Infectious Diseases, Tropical Medicine & AIDS, Academic Medical Center, F4-217, P.O. Box 22700, Amsterdam 1100 DE, the Netherlands b Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Program, Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho Chi Minh City, Viet Nam c Center for Infection and Immunity (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands d Division of Medical Microbiology, Academic Medical Center, Amsterdam, the Netherlands e Department of Virology, Cho Ray Hospital, Ho Chi Minh City, Viet Nam f Binh Thuan Medical College, Phan Thiet City, Viet Nam g Tropical Diseases Clinical Research Center, Cho Ray hospital, Ho Chi Minh City, Viet Nam h Center for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Center for Clinical Vaccinology and Tropical Medicine, Oxford, UK Summary Objectives—To explore clinical and virological characteristics and describe the epidemiology of dengue in patients who presented with acute undifferentiated fever (AUF) at primary health centers (PHC) in Binh Thuan Province, Vietnam. Methods—A prospective observational study was conducted from 2001 to 2006 to study the aetiology in AUF patients. Demographic and clinical information was obtained, and dengue polymerase chain reaction (RT-PCR) and serology were performed on a random selection of patients. Results—Three hundred fifty-one serologically confirmed dengue patients including 68 primary and 283 secondary infections were included in this study. In 25% (86/351) dengue virus (DENV) was detected by RT-PCR among which 32 DENV-1, 16 DENV-2, 1 DENV-3 and 37 DENV-4 were identified. The predominant dengue serotype varied by year with seasonal fluctuation: DENV-4 in 2001–2002, DENV-1 and DENV-2 from 2003 to 2006. Primary dengue was more common in children. Higher viraemia levels (P = 0.010) were found in primary infections compared to secondary infections. DENV-1 infected patients had higher viraemia levels than DENV-2 (P = 0.003) and DENV-4 (P < 0.001) infected patients. Clinical symptoms were often seen in adults. Few differences © 2010 Elsevier Ltd. Corresponding author. Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho Chi Minh City, Vietnam. Tel.: +84 8 9237954; fax: +84 8 9238904. [email protected]@oucru.org. This document was posted here by permission of the publisher. At the time of deposit, it included all changes made during peer review, copyediting, and publishing. The U.S. National Library of Medicine is responsible for all links within the document and for incorporating any publisher-supplied amendments or retractions issued subsequently. The published journal article, guaranteed to be such by Elsevier, is available for free, on ScienceDirect. Sponsored document from The Journal of Infection Published as: J Infect. 2010 March ; 60(3-2): 229–237. Sponsored Document Sponsored Document Sponsored Document

Transcript of Clinical, epidemiological and virological features of dengue virus infections in vietnamese patients...

Clinical, epidemiological and virological features of dengue virusinfections in vietnamese patients presenting to primary carefacilities with acute undifferentiated fever

Khoa T.D. Thaia,b,c,∗, Hoang Lan Phuonga,g, Tran Thi Thanh Ngae, Phan Trong Giaog, LeQuoc Hungg, Nguyen Van Namf, Tran Quang Binhg, Cameron Simmonsb,h, JeremyFarrarb,h, Tran Thinh Hienb, H. Rogier van Doornb,h, Menno D. de Jongb,d,h, and Peter J. deVriesa,c

aDivision of Infectious Diseases, Tropical Medicine & AIDS, Academic Medical Center, F4-217, P.O.Box 22700, Amsterdam 1100 DE, the Netherlands bOxford University Clinical Research Unit,Wellcome Trust Major Overseas Program, Hospital for Tropical Diseases, 190 Ben Ham Tu, District5, Ho Chi Minh City, Viet Nam cCenter for Infection and Immunity (CINIMA), Academic MedicalCenter, University of Amsterdam, Amsterdam, the Netherlands dDivision of Medical Microbiology,Academic Medical Center, Amsterdam, the Netherlands eDepartment of Virology, Cho Ray Hospital,Ho Chi Minh City, Viet Nam fBinh Thuan Medical College, Phan Thiet City, Viet Nam gTropicalDiseases Clinical Research Center, Cho Ray hospital, Ho Chi Minh City, Viet Nam hCenter forTropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Center for ClinicalVaccinology and Tropical Medicine, Oxford, UK

SummaryObjectives—To explore clinical and virological characteristics and describe the epidemiology ofdengue in patients who presented with acute undifferentiated fever (AUF) at primary health centers(PHC) in Binh Thuan Province, Vietnam.

Methods—A prospective observational study was conducted from 2001 to 2006 to study theaetiology in AUF patients. Demographic and clinical information was obtained, and denguepolymerase chain reaction (RT-PCR) and serology were performed on a random selection of patients.

Results—Three hundred fifty-one serologically confirmed dengue patients including 68 primaryand 283 secondary infections were included in this study. In 25% (86/351) dengue virus (DENV)was detected by RT-PCR among which 32 DENV-1, 16 DENV-2, 1 DENV-3 and 37 DENV-4 wereidentified. The predominant dengue serotype varied by year with seasonal fluctuation: DENV-4 in2001–2002, DENV-1 and DENV-2 from 2003 to 2006. Primary dengue was more common inchildren. Higher viraemia levels (P = 0.010) were found in primary infections compared to secondaryinfections. DENV-1 infected patients had higher viraemia levels than DENV-2 (P = 0.003) andDENV-4 (P < 0.001) infected patients. Clinical symptoms were often seen in adults. Few differences

© 2010 Elsevier Ltd.∗Corresponding author. Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho ChiMinh City, Vietnam. Tel.: +84 8 9237954; fax: +84 8 9238904. [email protected]@oucru.org.This document was posted here by permission of the publisher. At the time of deposit, it included all changes made during peer review,copyediting, and publishing. The U.S. National Library of Medicine is responsible for all links within the document and for incorporatingany publisher-supplied amendments or retractions issued subsequently. The published journal article, guaranteed to be such by Elsevier,is available for free, on ScienceDirect.

Sponsored document fromThe Journal of Infection

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

in clinical symptoms were found between primary and secondary infection and no significantdifferences in clinical symptoms between the serotypes were observed.

Conclusions—Our data provide insight in the epidemiology, clinical profile and virologicalfeatures of mild symptomatic dengue patients who presented to PHC with AUF in Vietnam.

KeywordsDengue; Epidemiology; Prospective study; Polymerase chain reaction; Vietnam

IntroductionMosquito-borne flavivirus infections such as dengue have rapidly spread and are now one ofthe most important infectious diseases in the world, in terms of morbidity and mortality. It isa public health problem with growing global incidence and geographic distribution to almostall tropical and subtropical regions, and with a transition from epidemic to endemictransmission intensity. Recent estimates indicate that over 3.5 billion people (∼55%) of theworld population are living in areas at risk for dengue.

Dengue is caused by an infection with a dengue virus (DENV) and transmitted primarily byAedes spp. mosquito vectors. Any of the four distinct serotypes (DENV 1–4) can cause denguefever (DF) or the more severe forms of the diseases: dengue hemorrhagic fever/dengue shocksyndrome (DHF/DSS). The majority of DENV infections are probably asymptomatic, and onlya small number of dengue infections (∼5%) will result in severe forms of the disease. Themechanisms for the variable clinical course are not completely elucidated, but interactionsbetween virus and host immunity and hyperendemicity of multiple serotypes are believed toplay an important role in determining the outcome of disease.

In Vietnam, dengue is not only an urban disease but also the high population density andecological conditions in the rural areas are also favourable for dengue transmission. BinhThuan, a rural province in southern Vietnam, is highly endemic for dengue. Dengue usuallypresents as a nonspecific febrile illness and is rarely recognized as a clinical entity by physiciansat primary health centers (PHC). However, recent studies have suggested that dengue is themost frequent cause of fever in patients who present to the PHC and is responsible forapproximately one-third of all patients with fever. The prevalence of dengue IgG antibodiesamong primary school children increased from 50% to 90% with increasing age, indicatinghigh, relatively stable, transmission rates over many years. The annual sero-conversion rateamong primary school children, corresponding to the annual incidence rate of primary dengueinfections, ranged from 12 to 17%.

The data presented here are derived from a prospective observational study from March 2001to March 2006, with enrolment of acute undifferentiated fever (AUF) patients who presentedto 12 PHCs and the provincial malaria control center in Binh Thuan province. One of theobjectives was to describe the epidemiology and to detect outbreaks of dengue in Binh Thuanprovince. In dengue endemic regions, outbreaks often do not necessarily reflect an increase intransmission intensity but merely an increased number of patients with complicated dengue,mostly secondary infections after the (re-)introduction of a new serotype. During the studyperiod no significant outbreaks of dengue were observed, other than the usual seasonalfluctuation. Here, we report PCR results for patients with serologically confirmed dengue andanalyze the epidemiology and clinical and virological characteristics with respect to serotype,antibody response and viraemia.

Thai et al. Page 2

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Material and methodsStudy site and population

The study site was described previously. Binh Thuan Province is located along the south-eastern coast of Vietnam, 150 km northeast of Ho Chi Minh City. It covers 7828 km2 and theestimated population was 1,140,429 inhabitants in 2004.

A prospective observational study was conducted from March 2001 to March 2006. In thisstudy, patients with AUF, who presented to the 12 study PHC and at the provincial malariacontrol station center in Phan Thiet city, were included. Patients were invited to participateafter giving informed consent. A standardized questionnaire was taken to collect demographicand clinical information. Serum samples were collected by venous puncture on presentation(acute sample; t0) and after 3 weeks (convalescent sample; t3). Serum samples were stored at−20 °C at the study sites until monthly transfer to Cho Ray hospital (Ho Chi Minh City,Vietnam), where they were stored at −70 °C.

Sample selection for serology and PCRComplete sets of acute and convalescent samples were collected for serology. In 2001 allcollected paired sera were tested with dengue ELISA; from 2002 onwards paired samples wererandomly selected as two patients per PHC and per month from the total dataset. Firstly, serumspecific anti-dengue IgM- and IgG-ELISA were performed in sera patients with AUF. Basedon the serological results, patients with DENV infection were included in this study. Secondly,RT-PCR was performed in the acute samples of patients with serologically confirmed dengue.

Dengue diagnosticsPaired serum samples were tested for dengue with direct IgG ELISA and IgM-Capture ELISA(Focus Technologies Inc., Cypress, CA, USA). Details regarding the ELISA and theinterpretation of results have been described previously. Briefly, a fourfold increase of antibodyconcentrations between t0 and t3 was considered significant. The IgM concentration on t3,relative to the IgG concentration on t3 was also used as a criterion. Acute primary dengue virusinfection was defined as positive IgM on t3 with an IgM/IgG ratio on t3 greater than one. Apositive IgM on t3 with an IgM/IgG ratio on t3 less than one, or a negative IgM reaction ont3 but with a positive IgG t3 and a fourfold molar increase of IgG between t0 and t3 wereclassified as acute secondary dengue. A negative IgM reaction on t3, a positive IgG on t3 butwithout a fourfold increase between t0 and t3 was classified as “not acute dengue but pastinfection”, and a case of both negative IgM and IgG on t3 was classified as “no dengue”.Dengue NS1 antigen was detected in a subset of serum samples using the Platelia™ DengueNS1 Ag − ELISA (Bio-Rad Laboratories, Inc., Hercules, CA, USA) according to themanufacturer's instructions. Optical density (OD) was measured at 450/620 nm, using theEvolis™ absorbance reader. Results were expressed as the OD ratio (ODR) between the ODvalue of the sample and a calibrator sample that is enclosed with every test panel. An ODR ≥ 1.0was interpreted as positive.

RNA was isolated from serum from the first serum as described elsewhere. RNA was reverselytranscribed, and dengue virus viraemia levels were assessed using an internally controlled,serotype specific, real-time reverse transcriptase polymerase chain reaction (RT-PCR) assaythat has been described elsewhere; results were expressed as cDNA equivalents per ml ofserum.

Thai et al. Page 3

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Ethical considerationsThe study was approved by the Review Board of Cho Ray Hospital, the provincial healthservices of Binh Thuan and the Peoples Committees of the participating communities. Allpatients (or, for children the parents or guardian) gave written informed consent.

Statistical analysisAll results were summarized in terms of medians and ranges for continuous data and non-parametric tests were used to compare within groups. For dichotomous variables, Fisher's exacttest was performed. Viraemia levels were expressed as the median and 25–75% interquartiles(25–75 IR). All calculations were performed using SPSS (version 16.0, SPSS Inc. Illinois). Atwo-tailed p-value of <0.05 was considered as statistically significant.

ResultsSample population

A total of 14,595 febrile patients were included. Eighty-three patients did not meet the inclusioncriteria and were excluded from further analysis. Paired sera were collected from 8268 febrilepatients; 1938 (23.4%) serum pairs were tested with dengue an IgM- and IgG-ELISA. Denguewas serologically confirmed in 382 (19.7%) cases. Of these, RT-PCR was performed in 351(91.9%) acute samples. DENV was detectable in 86 (24.5%) samples among which 32 wereDENV-1, 16 DENV-2, 1 DENV-3 and 37 DENV-4 were detected. Serologic testing by ELISArevealed 68 primary infections and 283 secondary infections. Demographic information on thestudy population is shown in Table 1.

Epidemiologic dataOccurrence of dengue serotypes—Dengue incidence in Binh Thuan peaks during therainy season from May to October. DENV-4 was the dominant dengue serotype in 2001–2002.Thereafter, DENV-1 and DENV-2 became the most frequently isolated serotype (Fig. 1).

Distribution of primary and secondary infection by age group—When age groupswere combined from patients selected for RT-PCR, acute secondary dengue (n = 283) was fourtimes as common as acute primary dengue (n = 68). The acute primary/secondary dengue ratioin children (<15 years of age) and adults were 0.49 and 0.12 (P < 0.001 by Fisher's exact test),respectively. Fig. 2 shows the serotypes which were found in 86 patients and the distributionof serologically confirmed primary and secondary DENV infections stratified by age group.

Clinical dataDifferences in clinical presentation between primary and secondary infection—Patients with secondary infection were more likely to be older than those with primary infection(P < 0.001). The median time between onset of fever and the first visit was 1 day (25–75 IR,2 days) for primary and secondary dengue. Myalgia was more frequently reported in secondaryinfection, whereas gastrointestinal symptoms were more common in primary infections (Table2).

Differences in clinical presentation between primary and secondary denguewith different serotypes—Primary infection was diagnosed in 17 of 32 DENV-1 patients(53.3%) and 1 of 16 DENV-2 patients (6.3%). All DENV-4 patients (n = 37) had an antibodyresponse that was compatible with secondary dengue. No significant differences betweenprimary DENV-1 and DENV-2 were observed with respect to the clinical variables. Clinicalvariables were also not significantly different between secondary DENV-1, DENV-2 andDENV-4 infections.

Thai et al. Page 4

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Differences in clinical presentation between children and adults—Table 2 alsoshows the distribution of clinical variables between children and adults. The median timebetween onset of fever and the first visit was 1 day (25–75 IR, 1 days) for both children andadults. Symptoms and physical findings were more common in adult patients, such as myalgia,backache, arthralgia, and bruises.

Virologic dataViraemia levels were measured in 71 of 86 RT-PCR positive patients (84%); 28 of 32 DENV-1,11 of 16 DENV-2, 1 of 1 DENV-3 and 32 of 37 DENV-4. The viraemia levels in serum rangedfrom 1.5 × 104 to 2.7 × 1011/mL, with a median of 1.1 × 106/mL (25–75 IR, 4.1 × 106/mL),and were sampled from day 0 to day 4 of fever.

Relationship between serum viraemia and antibody response—Viraemia levelswere significantly higher in primary than in secondary dengue (4.2 × 106/mL versus8.8 × 105/mL, respectively, P = 0.010, Fig. 3A). During the first two days of fever, viraemialevels were significantly higher in primary dengue than in secondary dengue (4.2 × 106/mLversus 9.6 × 105/mL, respectively, P = 0.036). The distribution of viraemia levels at differenttime points since illness days in primary and secondary dengue is shown in Fig. 3B.

Relationship between serum viraemia and the serotype—DENV-1 infected patientshad higher median viraemia levels than DENV-4 infected patients. Viraemia levels in DENV-1infected patients were higher than in DENV-2-infected patients. Viraemia levels in DENV-2and DENV-4 infected patients were not significantly different (Fig. 3C). When immune statuswas taken into account, median viraemia levels remained higher in secondary DENV-1 infectedpatients than secondary DENV-4 (5.5 × 106/mL versus 8.3 × 105/mL, respectively, P = 0.014)and secondary DENV-2 (5.5 × 106/mL versus 2.6 × 105/mL, respectively, P = 0.015) infectedpatients. No association was observed between serum viraemia levels and sex and age.

Relationship between serum viraemia and NS1 antigen—NS1 antigen detection wasperformed in 100 (of 351) acute samples; 40 samples were NS1 antigen positive. DENV wasdetectable in 31 (78%) of these samples and viraemia levels were measured in 20 samples.DENV was demonstrated in 3 of 60 NS1 antigen negative samples (5.0%). Irrespective ofimmune status, viraemia levels were higher in NS1 antigen positive patients than NS1 antigennegative patients (1.7 × 107/mL versus 8.6 × 104/mL, respectively) (P = 0.016, Mann–Whitneytest). Fig. 3D shows differences in viraemia levels among patients with and without NS1antigen by immune status. The median viraemia levels in patients with secondary DENVinfections with NS1 antigen were higher than those without NS1 antigen. Because of the smallnumbers, this did not reach significance (P = 0.100).

DiscussionIn a previous study we showed that dengue is highly endemic in Binh Thuan province insouthern Vietnam. Here we show that during a study period of five years, co-circulation ofmultiple DENV serotypes occurred in this region. Higher viraemia levels were found in primaryinfections in comparison to secondary infections. DENV-1 infected patients had higherviraemia levels than DENV-2 and DENV-4 infected patients. Clinical manifestations ofinfections with the different serotypes were similar but symptoms were more commonlyobserved in adults. Two symptoms differed significantly between primary and secondaryinfection which were myalgia and gastrointestinal symptoms.

The most prevalent serotype was DENV-4 during 2001 and 2002, followed by DENV-1 andDENV-2 in 2003. Although seasonal variations in virologically confirmed dengue cases wereobserved, these should be interpreted with caution, because only a proportion of AUF patients

Thai et al. Page 5

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

were tested by RT-PCR. A previous surveillance study showed that all four DENV serotypesco-circulated in southern Vietnam in 2001 with isolation of DENV-2 and DENV-3 in BinhThuan province. This study shows that all DENV serotypes have been circulating in BinhThuan province, probably with a shift of the dominant DENV serotype during the study period.Co-circulation of all DENV serotypes is well described in Asia and indicates hyperendemicity.

In discussing viraemia in relation to serotypes, it is important to point out that a primary immuneresponse was biased towards DENV-1, which accounted for 87% of primary DENV infections.DENV-1 infections were characterized by significantly higher viraemia levels than DENV-4infections and slightly higher than DENV-2 (Fig. 2D). DENV-1 infected patients are morelikely to be younger than DENV-2 or DENV-4 infected patients. Age is an important risk factorfor the development of severe dengue disease.

The relationship between viraemia and host antibody response is less clear and has been thetopic of many studies. In DENV-1 infections, viraemia was higher than in secondary infectionsbut this pattern was not found for DENV-2 infections for which lower viraemia was associatedwith higher anti-DENV antibody titres. Interestingly, primary immune status was found in halfof the symptomatic DENV-1 cases whereas 100% DENV-4 and almost all DENV-2 infectionsexhibited a secondary response. Likewise, primary infections with DENV-1 were predominantcompared to other serotypes in a retrospective study of Thai dengue cases. Analysis of a co-epidemic with DENV-2 and DENV-4 indicated that the vast majority of DENV-2 infectionswere associated with a secondary immune response.

DENV-2 viruses have most commonly been associated with DHF/DSS, along with DENV-1and DENV-3 viruses. DENV-2 and DENV-4 have been associated with increased diseaseseverity as a secondary infection, whereas DENV-1 and DENV-3 seem to cause more severedisease in primary infection than do the other two serotypes.

These data should be interpreted against their own history of DENV co-circulation and herdimmunity, which may be different between regions. In our study, clinical manifestations didnot differ significantly among patients infected with different serotypes but this was a studypopulation selected with only mild disease in a highly endemic area with a history of circulationof all DENV serotypes.

Our data showed sex differences with a male predominance. Reported sex differences arecontradicting and differences in favour of males have been documented. The underlying causesof sex differences are not clear and multiple factors may play a role. A plausible explanationcould be that there is a slight predominance in male births in Vietnam. A biased parents' healthseeking behaviours towards males, differences in susceptibility and clinical presentation areother plausible causes.

The strength of this study is the prospective enrolment of AUF patients over a period of fiveyears which provides a comprehensive overview of epidemiological pattern over time at PHCin Vietnam. Only AUF patients were tested for dengue and, therefore, the study populationincluded mildly symptomatic patients. Interestingly, a considerable amount (20%) of AUFpatients were seen with primary DENV infection at PHC. Health seeking behaviour and thenature of study site (at PHC) may have caused the identification of more symptomatic primarydengue infections. This study was conducted shortly after a period of time in which malariawas the main cause of fever. Public awareness that malaria causes fever was high. As resultsof which, febrile patients presented themselves very early at PHC. We previously showed thatpatient delay was shorter for children, suggesting that parents are very concerned about thehealth of their children and take the opportunity to seek help as soon as possible. These patientsare probably a true reflection of burden of symptomatic dengue in the general population.

Thai et al. Page 6

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

A limitation of this study is that serotypes identification by RT-PCR showed a low yield. Thereare several possible explanations for this low detection rate. First, serum samples werealiquoted and stored at −20 °C up to one month. Samples were collected for transportation toCRH hospital for storage at −70 °C once monthly. DENV RNA could have degraded due tosub-optimal storage and transport conditions. Secondly, samples were used previously for otherstudies. It is possible that several freeze–thawing steps contributed to the degradation of DENVRNA. Thirdly, the majority of our study population presented very early in course of dengueand clinical manifestations were very mild. At this early stage of disease, viraemia levels mayhave been low.

In conclusion, our data confirm earlier findings that dengue is highly endemic in southernVietnam and shows that all four serotypes are prevalent.

References1. World Health OrganizationDengue haemorrhagic fever. Diagnosis, treatment and control2nd ed.

1997WHOGeneva2. GublerD.J.Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic

problem in the 21st centuryTrends Microbiol1022002 Feb100103118278123. BeattyM.LetsonW.EdgilD.MargolisH.Estimating the total world population at risk for locally acquired

dengue infection. Abstract presented at the 56th Annual Meeting of the American Society of TropicalMedicine and HygieneAm J Trop Med Hyg77Suppl. 5200717025718165490

4. BlackW.C.BennettK.E.Gorrochotegui-EscalanteN.Barillas-MuryC.V.Fernandez-SalasI.deLourdesM.M.Flavivirus susceptibility in Aedes aegyptiArch Med Res3342002 Jul37938812234528

5. Rigau-PerezJ.G.ClarkG.G.GublerD.J.ReiterP.SandersE.J.VorndamA.V.Dengue and denguehaemorrhagic feverLancet35291321998 Sep 199719779752834

6. BurkeD.S.NisalakA.JohnsonD.E.ScottR.M.A prospective study of dengue infections in BangkokAmJ Trop Med Hyg3811988 Jan1721803341519

7. KyleJ.L.HarrisE.Global spread and persistence of dengueAnnu Rev Microbiol6220087192184296808. HaD.Q.TienN.T.HuongV.T.LoanH.T.ThangC.M.Dengue epidemic in southern Vietnam, 1998Emerg

Infect Dis642000 Jul422425109059839. PhuongH.L.de VriesP.J.NagelkerkeN.GiaoP.T.HungL.Q.BinhT.Q.Acute undifferentiated fever in

Binh Thuan province, Vietnam: imprecise clinical diagnosis and irrational pharmaco-therapyTropMed Int Health1162006 Jun86987916772009

10. PhuongH.L.de VriesP.J.NgaT.T.GiaoP.T.HungL.Q.BinhT.Q.Dengue as a cause of acuteundifferentiated fever in VietnamBMC Infect Dis6200612316869969

11. ThaiK.T.BinhT.Q.GiaoP.T.PhuongH.L.HungL.Q.Van NamN.Seroprevalence of dengue antibodies,annual incidence and risk factors among children in southern VietnamTrop Med Int Health1042005Apr37938615807802

12. ThaiK.T.NgaT.T.Van NamN.PhuongH.L.GiaoP.T.HungL.Q.Incidence of primary dengue virusinfections in southern Vietnamese children and reactivity against other flavivirusesTrop Med IntHealth12122007 Dec1553155718076564

13. NeffJ.M.MorrisL.Gonzalez-AlcoverR.ColemanP.H.LyssS.B.NegronH.Dengue fever in a PuertoRican communityAm J Epidemiol8611967 Jul1621844951556

14. TranT.N.de VriesP.J.HoangL.P.PhanG.T.LeH.Q.TranB.Q.Enzyme-linked immunoassay for denguevirus IgM and IgG antibodies in serum and filter paper bloodBMC Infect Dis620061316436203

15. PhuongH.L.ThaiK.T.NgaT.T.GiaoP.T.HungL.Q.BinhT.Q.Detection of dengue nonstructural 1(NS1) protein in Vietnamese patients with feverDiagn Microbiol Infect Dis2009 Feb 16

16. DussartP.LabeauB.LagathuG.LouisP.NunesM.R.RodriguesS.G.Evaluation of an enzymeimmunoassay for detection of dengue virus NS1 antigen in human serumClin VaccineImmunol13112006 Nov1185118916988003

Thai et al. Page 7

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

17. BoomR.SolC.BeldM.WeelJ.GoudsmitJ.Wertheim-van DillenP.Improved silica-guanidiniumthiocyanate DNA isolation procedure based on selective binding of bovine alpha-caseinto silica particlesJ Clin Microbiol3731999 Mar6156199986822

18. LaueT.EmmerichP.SchmitzH.Detection of dengue virus RNA in patients after primary or secondarydengue infection by using the TaqMan automated amplification systemJ Clin Microbiol3781999Aug2543254710405398

19. PhuongH.L.de VriesP.J.ThaiK.T.NgaT.T.HungL.Q.GiaoP.T.Dengue virus infections in Vietnam: tipof the icebergDengue Bull3020061525

20. HaD.Q.HuongV.T.LoanH.T.NguV.T.T.DaoH.T.N.ThangC.M.Virological and serologicalsurveillence of dengue epidemics in 19 provinces in southern Vietnam during 2001DengueBull2720034651

21. NisalakA.EndyT.P.NimmannityaS.KalayanaroojS.ThisayakornU.ScottR.M.Serotype-specificdengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999Am J TropMed Hyg6822003 Feb19120212641411

22. GuzmanM.G.KouriG.Dengue: an updateLancet Infect Dis212002 Jan33421189249423. KuberskiT.RosenL.ReedD.MataikaJ.Clinical and laboratory observations on patients with primary

and secondary dengue type 1 infections with hemorrhagic manifestations in FijiAm J Trop MedHyg2641977 Jul775783889017

24. MurgueB.RocheC.ChungueE.DeparisX.Prospective study of the duration and magnitude of viraemiain children hospitalised during the 1996–1997 dengue-2 outbreak in French PolynesiaJ MedVirol6042000 Apr43243810686027

25. YehW.T.ChenR.F.WangL.LiuJ.W.ShaioM.F.YangK.D.Implications of previous subclinical dengueinfection but not virus load in dengue hemorrhagic feverFEMS Immunol Med Microbiol4812006Oct849016965355

26. ThomasL.VerlaetenO.CabieA.KaidomarS.MoravieV.MartialJ.Influence of the dengue serotype,previous dengue infection, and plasma viral load on clinical presentation and outcome during adengue-2 and dengue-4 co-epidemicAm J Trop Med Hyg7862008 Jun99099818541782

27. BalmasedaA.HammondS.N.PerezL.TellezY.SaborioS.I.MercadoJ.C.Serotype-specific differencesin clinical manifestations of dengueAm J Trop Med Hyg7432006 Mar44945616525106

28. TheinS.AungM.M.ShweT.N.AyeM.ZawA.AyeK.Risk factors in dengue shock syndromeAm J TropMed Hyg5651997 May5665729180609

29. GrahamR.R.JuffrieM.TanR.HayesC.G.LaksonoI.Ma'roefC.A prospective seroepidemiologic studyon dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995–1996AmJ Trop Med Hyg6131999 Sep41241910497982

30. HarrisE.VideaE.PerezL.SandovalE.TellezY.PerezM.L.Clinical, epidemiologic, and virologicfeatures of dengue in the 1998 epidemic in NicaraguaAm J Trop Med Hyg631–22000Jul51111357995

31. VaughnD.W.GreenS.KalayanaroojS.InnisB.L.NimmannityaS.SuntayakornS.Dengue viremia titer,antibody response pattern, and virus serotype correlate with disease severityJ Infect Dis18112000Jan2910608744

32. AgarwalR.KapoorS.NagarR.MisraA.TandonR.MathurA.A clinical study of the patients with denguehemorrhagic fever during the epidemic of 1996 at Lucknow, IndiaSoutheast Asian J Trop Med PublicHealth3041999 Dec73574010928368

33. GohK.T.NgS.K.ChanY.C.LimS.J.ChuaE.C.Epidemiological aspects of an outbreak of dengue fever/dengue haemorrhagic fever in SingaporeSoutheast Asian J Trop Med Public Health1831987Sep2953023433161

34. Vietnam Ministry of Health & General Statistics. Population and Housing Census Vietnam; 1999.Available at: <http://www.gso.gov.vn/default.aspx?tabid = 503&ItemID = 1841>

35. TeerawichitchainanB.PhillipsJ.F.Ethnic differentials in parental health seeking for childhood illnessin VietnamSoc Sci Med6652008 Mar1118113018179851

36. PhuongH.L.de VriesP.J.BoonshuyarC.BinhT.Q.NamN.V.KagerP.A.Dengue risk factors andcommunity participation in Binh Thuan Province, Vietnam, a household surveySoutheast Asian JTrop Med Public Health3912008 Jan798918567446

Thai et al. Page 8

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

AcknowledgmentsThis study was carried out with the support of the Netherlands Foundation for the Advancement of Tropical Research(WOTRO) and the Wellcome Trust. Khoa T. D. Thai is supported by a ‘Mosaic’ fellowship from the NetherlandsOrganization for Scientific Research (NWO). This study would not have been possible without the contribution ofmany clinicians, nurses and co-workers at primary health centers across Binh Thuan Province. The authors thankNghiem My Ngoc and Nguyen Thien Quy for their laboratory help.

Thai et al. Page 9

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Figure 1.Co-occurrence of multiple dengue virus serotypes in Binh Thuan from 2001 to 2006.

Thai et al. Page 10

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Figure 2.Age group distribution of serologically (n = 1938) and RT-PCR (n = 86) confirmed denguevirus infection and serotypes among AUF patients in Binh Thuan province, 2001–2006.

Thai et al. Page 11

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Figure 3.Distribution of viraemia levels in: (A) patients with primary and secondary dengue infections;(B) patients with primary and secondary dengue infection and fever history; (C) patients withDENV-1, DENV-2, DENV-3 and DENV-4 infections; (D) patients with and without NS1antigen. All comparison within groups was performed using Mann–Whitney tests. Box plotsshow median values (horizontal line in the box), 25–75% interquartile range (lower-upperlimits of the box), 90% range of data (additional bars), and outliers (circles).

Thai et al. Page 12

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Thai et al. Page 13

Table 1

Demographic data of patients with acute undifferentiated fever and dengue.

Patients with AUF (N = 14512) Serologically confirmed/total tested(N = 351/1938)

Virologically confirmed/total tested(N = 86/351)

Male/female (ratio) 1.28a (8139/6373) 1.76 (224/127) 2.58 (62/24)

Median age (yr) (range) 18.3 (0.1–95.1)b 18.9 (4.2–73.7) 16.3(5.6–55.2)

Child/adult (ratio) 0.70 0.61 0.87

aSex was unknown in 7 AUF patients.

bAge was unknown in 8 AUF patients.

Published as: J Infect. 2010 March ; 60(3-2): 229–237.

Sponsored Docum

ent Sponsored D

ocument

Sponsored Docum

ent

Thai et al. Page 14

Table 2

Frequency of symptoms and physical findings on admission in patients diagnosed with primary, secondary andchildren and adults.

Variables Primary infection (N = 67a) Secondary infection (N = 283) P Children 5–15years (N = 132a)

Adult ≥15 years(N = 218)

P

Age (yr)b 12.2 (5.3–51.7) 20.6 (5.5–73.6) <0.001 11.2 (5.3–15.0) 28.1 (15.5–73.7)

Male/female 44/23 180/103 80/52 144/74

Body temperature (°C)b 38.9 (38.0–39.9) 39.0 (38.0–42.0) 39.0 (38.0–42.0) 39.0 (38.0–40.0)

Pulse pressure (mmHg)b 30.0 (30.0–60.0) 40.0 (20.0–60.0) <0.001 30.0 (20.0–55.0) 40.0 (20.0–60.0) <0.001

Heart rate (beats/min)b 90.0 (70.0–130.0) 90.0 (66.0–130.0) 95.0 (76.0–130.0) 90.0 (66.0–120.0) <0.001

Symptoms, (%)

Headache 91.0 94.7 92.4 95.0

Myalgia 29.9 52.7 0.001 25.8 61.9 <0.001

Sore throat 32.8 42.4 44.7 38.1

Backache 20.9 19.1 6.1 27.5 <0.001

Nausea 20.9 23.7 14.4 28.4 0.003

Cough 28.4 33.6 31.8 33.0

Arthralgia 16.4 17.7 10.6 21.6 0.009

Gastrointestinal symptoms 25.4 13.1 0.022 12.1 17.4

Findings at physical examination, (%)

Pallor 19.4 17.3 12.1 21.1 0.043

Dehydration 11.9 13.1 13.6 12.4

Pharyngitis 40.3 49.5 48.5 47.2

Lymph nodes 0.0 0.7 1.5 0.0

Rash 0.0 2.5 0.0 3.2

Bruises 6.0 4.2 0.8 6.9 0.007

aOne child (age = 4.2 years) was excluded from analysis.

bMedian (range); differences between groups were analyzed with Mann–Whitney tests. Fisher's exact test was used in all dichotomous data.

Gastrointestinal symptoms: abdominal pain, diarrhea and constipation.

Published as: J Infect. 2010 March ; 60(3-2): 229–237.